2024-06-14
Special thanks to Dr Jakub Piotrkowski PhD, Clinical Hospital of the Ministry of Internal Affairs and Administration with the Warmia-Mazury Oncology Centre in Olsztyn, Poland for sharing this case.
According to the available reference literature, recurrence in the lesion zone after thermal ablation in the liver occurs in approximately 12% of cases [1]. Based on the analysis of factors influencing the local recurrence post-thermal ablation, the relations to the adjacent vessels were listed. Both the size of the adjacent vessel and the absolute distance between the ablation zone and any near vessels affect the risk of recurrence in the treated area [2]. In this case, during the ablation procedure, the blood flow in the hepatic vein decreased the temperature in the area of thermal ablation, which directly reduced the effectiveness of the procedure in the area affected by high-frequency current. CEUS is a good tool for assessing the post-thermal ablation zone, among others, intraoperatively. Its first day sensitivity and specificity are comparable to CT [3]. For CEUS, the criteria for thermal ablation failure or local recurrence include irregular enhancement in the arterial phase and contrast washout in the portal phase [4].
Reference:
[1]. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005 Aug;242(2):158-71.
[2]. Odet J, Pellegrinelli J, Varbedian O, Truntzer C, Midulla M, Ghiringhelli F, Orry D. Predictive Factors of Local Recurrence after Colorectal Cancer Liver Metastases Thermal Ablation. J Imaging. 2023 Mar 10;9(3):66.
[3]. Meloni M.F., Andreano A., Franza E., Passamonti M., Lazzaroni S. Contrast enhanced ultrasound: Should it play a role in immediate evaluation of liver tumors following thermal ablation? Eur. J. Radiol. 2012;81:e897–e902.
[4]. Mauri G, Porazzi E, Cova L, Restelli U, Tondolo T, Bonfanti M, Cerri A, Ierace T, Croce D, Solbiati L. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014 Apr;5(2):209-16.